JF
ESPR icon

Jump Financial’s Esperion Therapeutics ESPR Stock Holding History

Jump Financial’s Portfolio ESPR Stock Details ESPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.89M Buy
+689,874
New +$2.18M 0.03% 677
2024
Q2 		– Sell
-38,762
Closed -$104K – 1925
2024
Q1 		$104K Buy
38,762
+12,939
+50% +$31.4K ﹤0.01% 1787
2023
Q4 		$77.2K Buy
+25,823
New +$33.5K ﹤0.01% 1687
2022
Q4 		– Sell
-56,600
Closed -$379K – 1699
2022
Q3 		$379K Sell
56,600
-5,400
-9% -$37.1K 0.01% 1021
2022
Q2 		$395K Buy
62,000
+7,400
+14% +$42K 0.02% 946
2022
Q1 		$253K Buy
+54,600
New +$234K 0.01% 1169
2021
Q4 		– Sell
-27,000
Closed -$326K – 1475
2021
Q3 		$326K Buy
+27,000
New +$393K 0.02% 623

Other funds holding ESPR

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return